While Pfizer first announced price increases for 100 medications July 1, the drugmaker decided to freeze the price hikes after scrutiny from President Trump.
Novartis on June 18 also shared plans to halt any drug price increases in the U.S. for the remainder of the year.
“Thank you to Novartis for not increasing your prices on prescription drugs. Likewise to Pfizer,” President Trump tweeted July 19. “We are making a big push to actually reduce the prices, maybe substantially, on prescription drugs.”
More articles on pharmacy:
Joining Pfizer, Novartis freezes price hikes in US
Novartis’ net income surges to $7.7B in Q2
5 latest drug, medical device recalls
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
